SLC16A7 and neoplasm: Consistently, daily administration of β-hydroxybutyrate via intra-peritoneal (i.p.)injection in mouse xenograft models promoted tumour growth of MDA-MB-231 and MDA-MB-157 cells, but not their MCT2-depleted counterparts (Fig. 4e).